IP Library › Granted Patent US 10,709,816
Granted Patent B2
US 10,709,816 · App. 14/234,681 · Granted Jul 14, 2020

Implant

Inventors: Olaf Andersen (Dresden, DE); Ingrid Morgenthal (Dresden, DE); Thomas Studnitzky (Dresden, DE); Frank Witte (Hannover, DE)
Assignees: Medizinische Hochschule Hannover (MHH); Fraunhofer-Gesekkschaft zur Foerderung der angewandten Forschung e.V.
A61L27/58A61B17/8085A61F2/02A61F2/28A61F2/30767A61L27/047A61L31/148B22F1/004B22F9/06C22C49/14A61B2017/00004A61B2017/00526A61F2002/30062A61F2002/3092A61F2002/30968A61F2310/00041Y10T29/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,709,816
App. No.
14/234,681
Filed
May 7, 2014
Granted
Jul 14, 2020
Kind
B2
Art Unit
3774
USPC
623/23.51
Abstract

The invention relates to implants that are implanted into living beings as temporary implants and that disintegrate in the body through biological adsorption over a period of time, in addition to a process for producing aforesaid implants. The implant according to the invention consists of magnesium or a magnesium master alloy. It is formed from fibers of magnesium or a magnesium master alloy that are connected to one another through sintering bridges that are locally spaced vis-à-vis each other and form an open-pored body. The fibers may be produced with the help of the melt extraction process and may subsequently be sintered with one another.

Claims (14)

1. Implant useful for bone in-growth consisting exclusively of a sintered bulked volume of packed layers of scattered fibers of a magnesium master alloy containing greater than 50% magnesium and excluding each of aluminium, copper, and nickel except in traces of maximally 1%, wherein the fibers have a length ranging from 2 mm to 15 mm and are securely connected to each other by sintered bridges that are locally spaced vis-à-vis one another and thereby form an open-pored body, which implant disintegrates in a living being through biological adsorption.

2. Implant according to claim 1 , characterized in that the magnesium master alloy is formed with at least one metal with which a liquid phase can be achieved at a temperature lower than the melting temperature of pure magnesium.

3. Implant according to claim 1 , characterized in that the magnesium master alloy contains at least one metal selected from the group consisting of Y, Zn, Ca, Mn, Pd, Ag, Sr, Bi, Si, Pr, Ga, Sc, Zr, Ce, Eu, La, Nd, Na and Li.

4. Implant according to claim 1 , characterized in that the implant has a porosity ranging from 50% to 95%.

5. Implant according to claim 1 , characterized in that at least part of the surface of the fibers has a magnesium oxide layer formed thereon.

6. Implant according to claim 5 , wherein the magnesium oxide layer has a layer thickness of at least 0.1 μm.

7. Implant according to claim 1 , characterized in that at least part of the surface of the fibers has a fluoride layer formed thereon.

8. Implant according to claim 7 , wherein the fluoride layer has a layer thickness of at least 0.1 μm.

9. Implant according to claim 1 , characterized in that areas with different porosity and strength are present.

10. Implant according to claim 1 , characterized in that the implant is connected to another implant.

11. Implant according to claim 1 , characterized in that the fibers have a length ranging from 5 mm to 10 mm.

12. Implant according to claim 1 , characterized in that the fibers have an outer diameter ranging from 0.05 mm to 0.5 mm.

13. Implant according to claim 1 , characterized in that the implant has a volume-specific surface ranging from 5000 m 2 /m 3 to 50000 m 2 /m 3 .

14. Implant according to claim 1 , wherein the fibers have a half-moon or sickle-shaped cross section.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2025
From: MEDIZINISCHE HOCHSCHULE HANOVER (MHH)
To: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Reel/Frame 072093/0916 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR IN THE NAME OF THE SECOND ASSIGNEE PREVIOUSLY RECORDED AT REEL: 032839 FRAME: 0942. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 22, 2014
From: ANDERSEN, OLAF; MORGENTHAL, INGRID; STUDNITZKY, THOMAS; WITTE, FRANK
To: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.; MEDIZINISCHE HOCHSCHULE HANOVER (MHH)
Reel/Frame 034690/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2014
From: ANDERSEN, OLAF; MORGENTHAL, INGRID; STUDNITZKY, THOMAS; WITTE, FRANK
To: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.; MEDIZINISCHE HOCHSCHUTE HANNOVER (MHH)
Reel/Frame 032839/0942 →
Continuity (1)
Related Publication 20140324188A1 · Oct 30, 2014
Cited By (3)
US 12,446,874 US 12,458,345 US 12,539,115